Literature DB >> 1888639

Morphine kinetics after diamorphine infusion in premature neonates.

D A Barrett1, A C Elias-Jones, N Rutter, P N Shaw, S S Davis.   

Abstract

1. The pharmacokinetics of morphine were studied in 26 newborn premature neonates (26-38 weeks gestational age) who were given a loading dose of 50 micrograms kg-1 of diamorphine followed by an intravenous infusion of 15 micrograms kg-1 h-1 of diamorphine. Plasma concentrations of morphine were measured during the infusion at steady-state and for 24 h after the cessation of the diamorphine infusion. 2. The mean steady-state plasma morphine concentration (+/- s.d.) for a diamorphine infusion rate of 15 micrograms kg-1 h-1 was 62.5 +/- 22.8 ng ml-1. 3. Morphine clearance was 3.6 +/- 0.9 ml min-1 kg-1, the elimination half-life was 8.9 +/- 3.3 h and the volume of distribution was 2.7 +/- 1.01 kg-1. 4. Morphine elimination kinetics were described by a mono-exponential function. 5. There was a direct relationship between the gestational age of the patients and the clearance (r2 = 0.31, P = 0.003) and half-life (r2 = 0.35, P = 0.01) of morphine, but no relationship was found between gestational age and volume of distribution. 6. The results suggest that the currently used dosing regimen of diamorphine achieves a safe and effective morphine concentration in the premature newborn but that the loading dose could be modified to achieve a more rapid onset of analgesia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1888639      PMCID: PMC1368489          DOI: 10.1111/j.1365-2125.1991.tb05609.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Sensitive and specific morphine radioimmunoassay with iodine label: pharmacokinetics of morphine in man after intravenous administration.

Authors:  R A Moore; D Baldwin; M C Allen; P J Watson; R E Bullingham; H J McQuay
Journal:  Ann Clin Biochem       Date:  1984-07       Impact factor: 2.057

2.  The pharmacokinetics of heroin in patients with chronic pain.

Authors:  C E Inturrisi; M B Max; K M Foley; M Schultz; S U Shin; R W Houde
Journal:  N Engl J Med       Date:  1984-05-10       Impact factor: 91.245

3.  Morphine pharmacokinetics: GLC assay versus radioimmunoassay.

Authors:  D R Stanski; L Paalzow; P O Edlund
Journal:  J Pharm Sci       Date:  1982-03       Impact factor: 3.534

4.  Determination of heroin and its metabolites by high-performance liquid chromatography.

Authors:  J G Umans; T S Chiu; R A Lipman; M F Schultz; S U Shin; C E Inturrisi
Journal:  J Chromatogr       Date:  1982-12-10

5.  Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine.

Authors:  B Dahlström; A Tamsen; L Paalzow; P Hartvig
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

6.  Alfentanil pharmacokinetics in preterm infants.

Authors:  N Marlow; A M Weindling; A Van Peer; J Heykants
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

7.  Morphine pharmacokinetics in early infancy.

Authors:  A M Lynn; J T Slattery
Journal:  Anesthesiology       Date:  1987-02       Impact factor: 7.892

8.  Variation in morphine pharmacokinetics in children with cancer.

Authors:  M C Nahata; A W Miser; J S Miser; R H Reuning
Journal:  Dev Pharmacol Ther       Date:  1985

9.  Pharmacokinetics of intravenous morphine in balanced anesthesia: studies in children.

Authors:  H Vandenberghe; S Mac Leod; H Chinyanga; L Endrenyi; S Soldin
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

10.  Evidence from opiate binding studies that heroin acts through its metabolites.

Authors:  C E Inturrisi; M Schultz; S Shin; J G Umans; L Angel; E J Simon
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

View more
  14 in total

Review 1.  Clinical pharmacokinetics of sedatives in neonates.

Authors:  E Jacqz-Aigrain; P Burtin
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

2.  Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.

Authors:  R D Hain; A Hardcastle; C R Pinkerton; G W Aherne
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

Review 3.  Prediction of morphine clearance in the paediatric population : how accurate are the available pharmacokinetic models?

Authors:  Elke H J Krekels; Dick Tibboel; Meindert Danhof; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2012-11       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

5.  An in vitro study of diamorphine permeation through premature human neonatal skin.

Authors:  D A Barrett; N Rutter; S S Davis
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

6.  Randomised, double blind trial of two loading dose regimens of diamorphine in ventilated newborn infants.

Authors:  D P Barker; J Simpson; M Pawula; D A Barrett; P N Shaw; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

7.  Morphine glucuronidation in premature neonates.

Authors:  R Hartley; M Quinn; M Green; M I Levene
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

8.  Pharmacokinetics of morphine infusion in premature neonates.

Authors:  R Hartley; M Green; M Quinn; M I Levene
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

9.  Morphine metabolism in neonates and infants.

Authors:  I Choonara; A Lawrence; A Michalkiewicz; A Bowhay; J Ratcliffe
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

10.  Prediction of glucuronidated drug clearance in pediatrics (≤5 years): An allometric approach.

Authors:  Iftekhar Mahmood
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-02-12       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.